(Q45996397)

18 December 2017

title

CD26/DPPIV cell membrane expression and DPPIV activity in plasma of patients with acute leukemia. (English)

1 reference

18 December 2017

Maria S Pombo-de-Oliveira

1 reference

object named as

Maria S Pombo-de-Oliveira

3

0 references

author name string

Camilla F C G de Andrade

1

1 reference

18 December 2017

Ricardo Bigni

2

1 reference

18 December 2017

Gilda Alves

4

1 reference

18 December 2017

Denise A Pereira

5

1 reference

18 December 2017

publication date

1 June 2009

1 reference

18 December 2017

Journal of Enzyme Inhibition and Medicinal Chemistry

published in

1 reference

18 December 2017

volume

24

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

708-714

1 reference

18 December 2017

CD26, let it cut or cut it down.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Functional role of CD26 on human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

Activation antigen expression on human T cells. I. Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802334800

10.1080/14756360802334800

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017